ACSL4 and chronic kidney disease: Immunofluorescence, real-time PCR, and spatial transcriptomics datasets (GSE139107) reveal decreased GPX4 expression in early AKI stages, with partial restoration during CKD progression, alongside persistently elevated ACSL4 levels in renal epithelial cells (Supplemental Figure 1, I and J).